Chimerix Inc (CMRX)
0.8924
-0.01
(-1.23%)
USD |
NASDAQ |
Sep 27, 16:00
0.8722
-0.02
(-2.26%)
After-Hours: 20:00
Chimerix SG&A Expense (TTM): 24.55M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 24.55M |
March 31, 2024 | 24.47M |
December 31, 2023 | 24.60M |
September 30, 2023 | 24.78M |
June 30, 2023 | 20.79M |
March 31, 2023 | 22.18M |
December 31, 2022 | 22.13M |
September 30, 2022 | 22.03M |
June 30, 2022 | 21.60M |
March 31, 2022 | 20.17M |
December 31, 2021 | 18.67M |
September 30, 2021 | 17.62M |
June 30, 2021 | 15.88M |
March 31, 2021 | 14.59M |
December 31, 2020 | 13.66M |
September 30, 2020 | 12.61M |
June 30, 2020 | 13.49M |
March 31, 2020 | 16.69M |
December 31, 2019 | 21.17M |
September 30, 2019 | 23.03M |
June 30, 2019 | 24.19M |
March 31, 2019 | 24.53M |
December 31, 2018 | 23.58M |
September 30, 2018 | 26.19M |
Date | Value |
---|---|
June 30, 2018 | 27.66M |
March 31, 2018 | 27.29M |
December 31, 2017 | 27.15M |
September 30, 2017 | 25.18M |
June 30, 2017 | 24.36M |
March 31, 2017 | 24.68M |
December 31, 2016 | 25.01M |
September 30, 2016 | 28.84M |
June 30, 2016 | 31.54M |
March 31, 2016 | 32.17M |
December 31, 2015 | 31.36M |
September 30, 2015 | 27.60M |
June 30, 2015 | 23.79M |
March 31, 2015 | 20.98M |
December 31, 2014 | 17.53M |
September 30, 2014 | 14.39M |
June 30, 2014 | 11.70M |
March 31, 2014 | 9.463M |
December 31, 2013 | 8.327M |
September 30, 2013 | 7.194M |
June 30, 2013 | 7.001M |
March 31, 2013 | 6.358M |
December 31, 2012 | 6.748M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
12.61M
Minimum
Sep 2020
24.78M
Maximum
Sep 2023
19.73M
Average
20.98M
Median
SG&A Expense (TTM) Benchmarks
SIGA Technologies Inc | 26.79M |
Abbott Laboratories | 11.34B |
Emergent BioSolutions Inc | 346.30M |
Tonix Pharmaceuticals Holding Corp | 37.14M |
Geovax Labs Inc | 5.655M |